COVID-19 TCTMD HUB

Todd Neale

COVID-19: TCTMD’s Daily Dispatch

TCTMD reporter Todd Neale is keeping up on breaking news and peer-reviewed research related to COVID-19 and will update accordingly. If you have something to share, tell us.

LATEST NEWS

Thursday, June 17

AI-Enhanced ECG Shows Potential for COVID-19 Screening

The approach might be of use in the emergency department, but not for large-scale screening of the public, one expert says.

Monday, June 14

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Observational data trace the swift but widely variable uptake of anticoagulants, and offer clues to the most effective doses.

Monday, June 11

Myocarditis in Young People After mRNA COVID-19 Vaccination Higher Than Expected

The CDC is continuing to monitor the potential risks, but experts say the adverse event is rare and the benefits far outweigh risks.

Monday, June 10

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

The updated estimates can help in discussions with patients about the risks and benefits of adenovirus-based vaccination.

Monday, June 7

Korean Kawasaki Cases Dropped Sharply Amid COVID-19 Controls

Nonpharmaceutical interventions such as masks and social distancing were likely what helped, offering clues on etiology.

Monday, May 24 | ACC 2021

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

The AHA says the benefits of getting the shot still “enormously outweigh” any small related risk of myocarditis, if it exists.

Monday, May 17 | ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

A marked increase in bleeding outweighed any potential modest reduction in thrombotic events versus standard prophylaxis.

Monday, May 17 | ACC 2021

COVID-19 Doubled Burnout Rates in Cardiology

The responsibility for change needs to be shared between hospitals, policymakers, and clinicians, says ACC’s president.

Sunday, May 16 | ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Full trial results showed numerically lower event rates with the SGLT2 inhibitor and importantly no major signal of ketoacidosis.

Wednesday, May 12

No Long-term CV Impact With Mild COVID-19, Two New Studies Reassure

WA study of UK healthcare workers and another in college athletes reject the role of CV imaging after mild or asymptomatic disease.

Friday, May 7 | ACC 2021

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Work flexibility and other means of reducing exposure were harder to come by for those with social determinants of health.

Thursday, May 6

VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms

Whether the benefit-risk balance is favorable depends on many factors, but it will be so “in very many cases,” the researcher says.

Friday, April 30

AHA/ASA Offers Advice on Rare Blood Clots Seen After Vaccines for COVID-19

TThe group continues to urge everyone to get vaccinated as soon as possible, saying the benefits outweigh any potential risks.

Wednesday, April 28

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

The largest study to date looking at new heart failure diagnoses after a COVID-19 admission offers reassurances and caveats.

Monday, April 26

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

Amputations rose in New York, the UK expanded “hot clinics,” and the FDA worked to understand the impact on trialists.

Thursday, April 22

Large Registry Reassures on COVID-19’s CV Impact

How SARS-CoV-2 might damage the heart, even after mild illness, is unclear. New data in college athletes may quell concerns.

Friday, April 16

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

This is the second NEJM paper to highlight anti-PF4 antibodies as a cause for thrombotic events with the AstraZeneca/Oxford shot.

Wednesday, April 21

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Offering opportunities for widespread, iterative learning and increased efficiency, remote learning is here to stay, experts say.

Monday, February 8

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Interim results from an international, multiplatform RCT have been released, but experts urge caution before changing practice.

Wednesday, January 20

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

Nurses and techs are quitting permanent jobs for lucrative traveling contracts, leaving hospitals and cath labs scrambling.

Monday, January 11

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Editors grappled with study volume and quality but wanted to publish something—ANYTHING—on the virus’s CV effects.

Monday, December 14

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

The pandemic revealed that research doesn’t have to be the lumbering creature it’s been and can be more agile and efficient.

Thursday, December 10

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

For all the grief and loss it’s caused, the pandemic may trigger some needed shifts and shine a light in the shadows.

Monday, November 2

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

The pandemic is reviving debate around universal ECG screening, but recommendations remain focused on more-targeted testing.

Wednesday, July 29

Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery

Cardiology groups large and small used different tactics to keep afloat and continue patient care. The future remains unclear.

Monday, July 20

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Cardiac complications in COVID-19 have thwarted acute care. Now physicians are asking what this portends down the road.

Advertisement